Insider Transactions in Q2 2021 at Strongbridge Biopharma PLC (SBBP)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
May 18 2021	David N Gill Director	BUY Grant, award, or other acquisition	Direct	40,000 +29.45%	-
May 18 2021	Garheng Kong Director	BUY Grant, award, or other acquisition	Direct	40,000 +32.85%	-
May 18 2021	Jeffrey W Sherman Director	BUY Grant, award, or other acquisition	Direct	40,000 +32.78%	-
May 18 2021	Marten Steen Director	BUY Grant, award, or other acquisition	Indirect	40,000 +32.81%	-
May 18 2021	Hilde H Steineger Director	BUY Grant, award, or other acquisition	Direct	40,000 +32.78%	-
May 17 2021	Richard S Kollender President and CFO	SELL Payment of exercise price or tax liability	Direct	11,392 -3.48%	$22,784 $2.28 P/Share
May 14 2021	Marten Steen Director	SELL Payment of exercise price or tax liability	Indirect	19,004 -31.2%	$38,008 $2.35 P/Share
May 14 2021	David N Gill Director	SELL Payment of exercise price or tax liability	Direct	19,075 -25.47%	$38,150 $2.35 P/Share
May 14 2021	Jeffrey W Sherman Director	SELL Payment of exercise price or tax liability	Direct	18,944 -31.07%	$37,888 $2.35 P/Share
May 14 2021	Hilde H Steineger Director	SELL Payment of exercise price or tax liability	Direct	18,944 -31.07%	$37,888 $2.35 P/Share
May 14 2021	Garheng Kong Director	SELL Payment of exercise price or tax liability	Direct	19,200 -31.5%	$38,400 $2.35 P/Share
Apr 08 2021	John Johnson Chief Executive Officer	SELL Payment of exercise price or tax liability	Direct	17,325 -1.71%	$34,650 $2.68 P/Share

Receive a notification when an Institution or Guru buys or sells SBBP shares.

Notify only if

Value

Get notified when an Strongbridge Biopharma PLC insider buys or sells SBBP shares.

Notify only if

Operation

Value

Type

Receive news related to Strongbridge Biopharma plc